ArticleBlood advances2019

Long-term outcome of patients with relapsed/refractory B-cell non-Hodgkin lymphoma treated with blinatumomab.

Vera Dufner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.